tirzepatide injection new windsor Flex-Dose 4 mL Injectable 10 mg/mL Tirzepatide Injection | Starts at

Another recommends 500mcg

Primary Uses and FDA Approvals Ozempic Primary FDA approval: Type 2 diabetes management Secondary benefit: Weight loss Typical weekly doses: 0.25 mg to 2 mg Wegovy Primary FDA approval: Chronic weight management Specifically approved for: Adults with BMI 30, or Adults with BMI 27 with at least one weight-related condition Typical weekly doses: 0.25 mg to 2.4 mg Key Differences (Wegovy vs Ozempic) Dosing Protocol Wegovy follows a more gradual dose escalation pattern and reaches a higher maximum dose than Ozempic

Appetite and hunger signals begin returning more substantially, though most people don't experience the full baseline hunger they felt before starting treatment

Until evidence-based guidelines define the optimal duration for holding GLP-1 agonists before procedures, POC ultrasound may be a useful tool to assess aspiration risk